ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 536

Prevalence and Relative Factors for Frailty in Patients with RA from a Prospective Observational Study

Masahiro Tada1, Yutaro Yamada2, Koji Mandai3 and Noriaki Hidaka4, 1Orthopaedic Surgery, Osaka City General Hospital, Osaka, Japan, 2Orthopedic surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 3Orthopaedic surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 4Orthopaedic surgery, Osaka City General Hospital, Osaka, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Disease Activity, observation and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Prevalence and relative factors for frailty in patients with RA from a prospective observational study

Background/Purpose: Frailty is defined as degradation of physical and cognition function in elderly adult. The characteristics of frailty include not only physical problems as co-morbidity and disability, but also mental and social problems. It is unclear of relationship between frailty and disease activity of patients with rheumatoid arthritis (RA). We investigated the relative factors about frailty in patients with RA from a prospective observational study.

Methods: 95 from 100 patients entered the CHIKARA study (Correlation researcH of sarcopenIa, sKeletal muscle and disease Activity in Rheumatoid Arthritis) were investigated by frailty check list (maximal score is 25). According to reported article, frailty was defined from 8 to 25 and pre-frailty was from 4 to 7, and normal was from 0 to 3. We investigated relationship of disease activity in frailty, pre-frailty and normal groups, and analyzed the relative factors for frailty.

Results: The prevalence of frailty, pre-frailty, and normal was 19%, 39% and 42%, respectively. The character of groups indicated at Table 1. Frailty group was the oldest of three groups. Disease activity sore 28 erythrocyte sedimentation rate (DAS28ESR) and matrix metalloproteinase 3 (MMP3) of frailty group was higher than those of pre-frailty and normal groups. Whereas, modified health assessment questionnaire (mHAQ) of frailty group was lower than those of pre-frailty and normal groups. Normal was 66.6% and frailty was 6.7% in remission patients. However, Normal was 13.3% and frailty was 46.7% in moderate and high disease activity patients. The prevalence of frailty was increased with disease activity. The relative factors for frailty in patients with RA indicated at Table 2. Age, locomotive syndrome, DAS28ESR, mHAQ, and Steinbroker class were related positively and leg muscle score and grip strength were related negatively by univariate analysis. Steinbroker class (odds ratio: 3.25 95%CI: 1.11-9.51, P=0.031) and mHAQ (odds ratio: 1.29, 95%CI: 1.13-1.46, P<0.001) were independent relative factors by multivariate analysis.

Conclusion: It was revealed that frailty involved disease activity and physical function in patients with RA. Control of disease activity is important to prevent not only disease progression, but also frailty.

Table 1. The character of frailty, pre-frailty, and normal in patients with RA

Frailty (19%)

Pre-frailty (39%)

Normal (42%)

P value

Age, years

72.5 ± 10.3

68.6 ± 11.3

60.7 ± 16.4

0.01

Leg muscle score

84.9 ± 5.9

86.2 ± 6.4

93.2 ± 9.7

<0.001

Grip, kg

12.6 ± 6.9

17.7± 7.1

18.1± 6.2

0.013

Locomotive 5 score

11.1 ± 5.8

6.4 ± 4.9

2.6 ± 4.0

<0.001

MMP3, ng/dl

143.7 ± 122.0

95.9 ± 66.0

88.6 ± 52.0

0.033

DAS28ESR

3.62 ± 0.97

3.27 ± 1.02

2.83 ± 0.96

0.015

mHAQ

0.9 ± 0.7

0. 4 ± 0.2

0.1 ± 0.1

<0.001

Sarcopenia, %

39

41

18

0.063

Table 2. Relative factors for frailty in patients with RA

Univariate

Multivariate

R value

P value

Odds ratio

95%CI

Age, years

0.203

0.048

Locomotive syndrome

0.397

<0.001

Leg muscle score

-0.222

0.031

Grip strength, kg

-0.272

0.008

DAS28ESR

0.228

0.026

mHAQ

0.413

<0.001

1.29

1.13-1.46

Steinbrocker class

0.331

0.001

3.25

1.11-9.51


Disclosure: M. Tada, None; Y. Yamada, None; K. Mandai, None; N. Hidaka, None.

To cite this abstract in AMA style:

Tada M, Yamada Y, Mandai K, Hidaka N. Prevalence and Relative Factors for Frailty in Patients with RA from a Prospective Observational Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/prevalence-and-relative-factors-for-frailty-in-patients-with-ra-from-a-prospective-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-relative-factors-for-frailty-in-patients-with-ra-from-a-prospective-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology